Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
2021 · The Lancet Psychiatry · 764 citations
https://doi.org/10.1016/s2215-0366(21)00251-0
Y
Yifeng Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
358
Papers
15.6K
Citations
42
h-index
148
i10-index
Yifeng Xu is an academic researcher from National Defense University. The author has contributed to research in topics: Schizophrenia research and treatment & Genetic Associations and Epidemiology & Mental Health Treatment and Access. The author has an h-index of 42, co-authored 305 publications.
ORCID: 0000-0002-0403-1141Papers by this author
worksThe MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China
2015 · Schizophrenia Research · 301 citations
https://doi.org/10.1016/j.schres.2015.09.003
Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies
2014 · BMC Psychiatry · 206 citations
https://doi.org/10.1186/s12888-014-0321-9
Attapulgite modulated thorny nickel nanowires/graphene aerogel with excellent electromagnetic wave absorption performance
2021 · Chemical Engineering Journal · 81 citations
https://doi.org/10.1016/j.cej.2021.128976
A Pilot Study of the Efficacy and Safety of Paroxetine Augmented With Risperidone, Valproate, Buspirone, Trazodone, or Thyroid Hormone in Adult Chinese Patients With Treatment-Resistant Major Depression
2011 · Journal of Clinical Psychopharmacology · 59 citations
https://doi.org/10.1097/jcp.0b013e31822bb1d9
Comparisons of the Efficacy and Tolerability of Extended-Release Venlafaxine, Mirtazapine, and Paroxetine in Treatment-Resistant Depression
2010 · Journal of Clinical Psychopharmacology · 54 citations
https://doi.org/10.1097/jcp.0b013e3181e7784f
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat